Nachrichten zur Astrazeneca PLC (Spons. ADRs) Aktie

JPMorgan belässt Astrazeneca auf Overweight - Ziel 14000 Pence

NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat Astrazeneca mit einem Kursziel von 14000 Pence auf "Overweight" belassen. Auf…

AstraZeneca says staff detained in China amid reports of a drug-import investigation

Some employees of British pharmaceutical giant AstraZeneca have been detained by police in China as part of an investigation, the…

AstraZeneca confirms five employees held by China police

AstraZeneca PLC (LSE:AZN) has confirmed that five current and former employees in China are being held by police for questioning.…

AstraZeneca slides after confirming five employees held by China police

AstraZeneca PLC (LSE:AZN) shares fell 3.5% after it confirmed that five current and former employees in China are being held by…

China Detains AstraZeneca Staff in Data, Drug-Import Probes

Police in China have detained five current and former employees of British drugmaker AstraZeneca Plc for questioning about potential illegal…

Total Voting Rights

2 September 2024 15:00 BST Transparency Directive Voting rights and capital The following notification is made in accordance with the UK Financial Conduct…

Gothenburg and AstraZeneca deepen ties to strengthen life science sector

Gothenburg is to get its first regional business strategy for life science. The initiative comes from Business Region Göteborg and…

QIAGEN and AstraZeneca Expand Pact to Develop CDx in Chronic Diseases

QGENs expanded collaboration with AstraZeneca to focus on developing companion diagnostics beyond oncology.…

Qiagen mit aussichtsreicher Kooperation

Qiagen sammelt einen weiteren Pluspunkt. Der Spezialist im Bereich der molekularen Diagnostik kann die bisherige strategische Partnerschaft mit AstraZeneca ausweiten.…

GNW-Adhoc: Partnerschaft für Begleitdiagnostika für chronische Krankheiten: QIAGEN weitet Anwendung von QIAstat-Dx auf die Präzisionsmedizin aus

^Neue Vereinbarung erweitert die Zusammenarbeit mit AstraZeneca über dieOnkologie hinaus - einschließlich komplexer chronischer Erkrankungen // QIAGENssyndromische Testplattform QIAstat-Dx ermöglicht…

Top Analyst Reports for Linde, AstraZeneca & Walt Disney

Todays Research Daily features new research reports on 16 major stocks, including Visa Inc. (V), AstraZeneca PLC (AZN) and The…

AstraZeneca (AZN) Denies Rumors About UK Facility Relocation

Per third-party reports, AstraZeneca (AZN) has refuted rumors about considering a change in the relocation of a vaccine manufacturing plant…

AstraZeneca warns of moving UK vaccine production to US, FT reports By Reuters

AstraZeneca warns of moving UK vaccine production to US, FT reports…

Billion-dollar Deals in Radiopharmaceuticals Catch Investor Attention

Recent mergers and acquisitions and partnership deals in the medical industry are showing signs of increasing investor interest in the…

Imfinzi approved in US for resectable lung cancer

16 August 2024  Imfinzi approved in the US for the treatment of resectable non-small cell lung cancer before and after surgery Based on AEGEAN…

Pharma Stock Roundup: AZN Gets Approvals for Imfinzi Expanded Use, MRK Inks New Deal

Merck (MRK) signs a new collaboration with a private drugmaker. AstraZeneca (AZN) gets approvals for expanded use of Imfinzi.…

FDA Expands AstraZenecas (AZN) Imfinzi Label in Lung Cancer

This approval is based on late-stage study data, which shows that treatment with AstraZenecas (AZN) Imfinzi reduced the risk of…

How Should You Play AstraZeneca (AZN) After Q2 Beat, View Raise?

AstraZenecas (AZN) key drugs like Lynparza, Tagrisso, Imfinzi, Ultomiris and Farxiga should drive sales. Its pipeline is huge, with several…

GOLDMAN SACHS stuft ASTRAZENECA auf Buy

NEW YORK (dpa-AFX Analyser) - Die US-Investmentbank Goldman Sachs hat die Einstufung für Astrazeneca nach veröffentlichten Fachartikeln für die anstehende…

Puma Biotech drops after patents ruled invalid in fight with AstraZeneca over Tagrisso

…

AstraZeneca’s Market Cap Soars Past £200 Billion for First Time

AstraZeneca Plc has become the first British company to be valued at more than £200 billion ($257 billion) after a…

The state of digital health investment, part 3: AstraZeneca

Sonny Shergill, vice president of commercial digital health at AstraZeneca, highlights pharmas perspective on digital health investments and partnerships for…

Conduit Pharmaceuticals Enters into Exclusive License Agreement with AstraZeneca for Multiple Assets to Advance Potential First-in-Class Treatments

Conduit Pharmaceuticals Enters into Exclusive License Agreement with AstraZeneca for Multiple Assets to Advance Potential First-in-Class Treatments…

Top Analyst Reports for AstraZeneca, TotalEnergies & ConocoPhillips

Todays Research Daily features new research reports on 16 major stocks, including AstraZeneca PLC (AZN), TotalEnergies SE (TTE) and ConocoPhillips…

How Should You Play AstraZeneca (ABBV) After Q2 Beat, View Raise?

AstraZenecas (AZN) key drugs like Lynparza, Tagrisso, Imfinzi, Ultomiris and Farxiga should drive sales. Its pipeline is huge, with several…

Heres What AstraZenecas CEO Has to Say About the Weight Loss Drugs Market

The winners of today might not compete in the lucrative new segment of tomorrow.…

Total Voting Rights

1 August 2024 15:00 BST Transparency Directive Voting rights and capital The following notification is made in accordance with the UK Financial Conduct…

AstraZeneca prices a €1.4bn bond offering

30 July 2024 07:00 BST AstraZeneca prices €1.4 billion bond offering AstraZeneca PLC (the Company) announces that, on 29 July 2024, its…

DEUTSCHE BANK RESEARCH stuft ASTRAZENECA auf Hold

FRANKFURT (dpa-AFX Analyser) - Deutsche Bank Research hat die Einstufung für Astrazeneca auf "Hold" mit einem Kursziel von 11000 Pence…

Calquence fixed-duration combo improved 1L CLL PFS

29 July 2024 Fixed-duration Calquence plus venetoclax, with or without obinutuzumab, significantly improved progression-free survival in 1st-line chronic lymphocytic leukaemia in AMPLIFY Phase III…

ODAC reviewed Imfinzi in resectable lung cancer

26 July 2024 FDA Advisory Committee reviewed Imfinzi for treatment of resectable non-small cell lung cancer based on AEGEAN Phase III trial results The…

Pharma Stock Roundup: AZN, SNY, ABBV Q2 Earnings, PFE & MRKs Positive Pipeline News

AstraZeneca (AZN), Sanofi (SNY) and AbbVie (ABBV) announce second-quarter results. Merck (MRK) and Pfizers (PFE) phase III studies achieve primary…

AstraZeneca PLC (AZN) Q2 2024 Earnings Call Transcript

…

AstraZeneca Plc (AZN) Q2 2024 Earnings Call Transcript

AZN earnings call for the period ending June 30, 2024.…

AstraZeneca, Roche Intensify New Drug Push, Automakers Sink Post-Earnings | The Opening Trade 07/25

2 and half trillion dollar Thursday. Thats the market cap of firms reporting on the busiest day for European earnings.…

AstraZeneca shares fall despite guidance raise as drugmaker warns on income By Investing.com

AstraZeneca shares fall despite guidance raise as drugmaker warns on income…

ROUNDUP: Astrazeneca erhöht Prognose - Kostenentwicklung sorgt Anleger

CAMBRIDGE (dpa-AFX) - Der Pharmakonzern Astrazeneca hat nach dem zweiten Quartal seine Jahresprognose angehoben. Umsatz und Gewinn je Aktie…

AstraZeneca posts very respectable first half results

The drop in AstraZeneca shares on Thursday was more a consequence of a wider market selloff than disappointed with the…

WDH: Astrazeneca übertrifft Erwartungen im zweiten Quartal - Höhere Prognose

(Tippfehler berichtigt) CAMBRIDGE (dpa-AFX) - Der Pharmakonzern Astrazeneca hat nach einem starken zweiten Quartal seine Jahresprognose…

FTSE 100 live: Stocks rebound from three-month low, Unilever, BAT and Lloyds gain

FTSE 100 climbs 19 points to 8,173 Results out from AstraZeneca, Unilever, BAT, Lloyds ...and BT, Vodafone, Centrica, Airtel, Rentokil, Mitchells &...…

FTSE 100 live: Stocks rebound after hitting three-month low, mixed start for Wall Street

FTSE 100 climbs 3 points to 8,156 Results out from AstraZeneca, Unilever, BAT, Lloyds ...and BT, Vodafone, Centrica, Airtel, Rentokil, Mitchells &...…

FTSE 100 live: Index plunges to three-month low, as AstraZeneca, Lloyds and Centrica fall

FTSE 100 drops 70 points to 8,084 Results out from AstraZeneca, Unilever, BAT, Lloyds ...and BT, Vodafone, Centrica, Airtel, Rentokil, Mitchells &...…

FTSE 100 live: Stocks rebound from three-month low, US tech rout continues

FTSE 100 climbs 12 points to 8,166 Results out from AstraZeneca, Unilever, BAT, Lloyds ...and BT, Vodafone, Centrica, Airtel, Rentokil, Mitchells &...…

FTSE 100 live: Index plunges to three-month low, as AstraZeneca falls, Unilever jumps

FTSE 100 drops 83 points to 8,070 Lloyds profits just beat forecasts Results out from AstraZeneca, BT, Vodafone, Unilever, BAT, Centrica,…

FTSE 100 live: London stocks plunge to three-month low, US tech heading lower

FTSE 100 drops 40 points to 8,114 Results out from AstraZeneca, Unilever, BAT, Lloyds ...and BT, Vodafone, Centrica, Airtel, Rentokil, Mitchells &...…

FTSE 100 live: London stocks plunge to three-month low, US tech to extend losses

FTSE 100 drops 23 points to 8,130 Results out from AstraZeneca, Unilever, BAT, Lloyds ...and BT, Vodafone, Centrica, Airtel, Rentokil, Mitchells &...…

FTSE 100 live: Stocks rebound from three-month low, US tech sell-off continues

FTSE 100 climbs 1 points to 8,154 Results out from AstraZeneca, Unilever, BAT, Lloyds ...and BT, Vodafone, Centrica, Airtel, Rentokil, Mitchells &...…

AstraZeneca beats top-line and bottom-line estimates; raises FY24 outlook

…

AstraZeneca lifts full-year outlook on upbeat demand for therapies By Reuters

AstraZeneca lifts full-year outlook on upbeat demand for therapies…

Half-year Report

AstraZeneca 25 July 2024 H1 and Q2 2024 results Strong underlying growth supports FY 2024 guidance upgrade, with both Total Revenue and Core…